Jorge Melendez-Zajgla

25PUBLICATIONS
63CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical mycologyEarly English languagesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 13, 2026
Mechanisms of Hydroxyurea-Mediated DNA Damage Potentiation in Fanconi Anemia Cells.

|Jan 28, 2026
Pancreatic Cancer Stem Cells Co-Expressing SOX2, OCT4, and TERThigh Represent an Aggressive Subpopulation.

Erika Curiel-Gomez, Damaris P Romero-Rodriguez, Mauricio Rodriguez-Dorantes

|Nov 27, 2025
Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma.

Jonathan Gonzalez-Ruiz, Miryam Sarmiento-Casas, Ivan Bahena-Ocampo

|Nov 13, 2025
Comprehensive Epigenome-Wide Profiling Reveals Distinctive DNA Methylation Signatures and Potential Prognostic Biomarkers in Mexican Pediatric B-ALL.

Alan Alberto Fong-López, Juan Carlos Núñez-Enríquez, Vilma Carolina Bekker-Méndez

|Jun 26, 2025
Editorial: Advancing Molecular Oncology in Mexico.

Jorge Melendez-Zajgla, Ignacio Camacho-Arroyo, Mahara A Valverde Ramirez

Pageof 5